ENOBLITUZUMAB
UNII M6030H73N9

Substance Identification & Data

This profile provides standardized clinical and technical data for Enoblituzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M6030H73N9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1353485-38-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
M6030H73N9
CAS Registry Number
1353485-38-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ENOBLITUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C97510
National Cancer Institute reference terminology for clinical and research data.
INN ID
10165
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
BC-80
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enoblituzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENOBLITUZUMAB

Common Names & Synonyms

ENOBLITUZUMAB [INN]
ENOBLITUZUMAB [USAN]
ENOBLITUZUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(ANTIGEN B7-H3) (HUMAN-MUS MUSCULUS MONOCLONAL MGA271 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MGA271 K-CHAIN, DIMER

Technical Codes

MGA271
MGA-271

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus